Racivir
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2002 (NCT00040300)
Timeline
Indications
Studied for
Mechanism of action
- Reverse transcriptaseINHIBITOR
Reverse transcriptase inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- (+/-)-emtricitabine
- racivir
- racivir
- racivir
- rcv
- rcv
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00121979 | Phase 2 | Sep 1, 2004 | Northwestern University, Pharmasset |
| NCT00040300 | Phase 1 | Jun 1, 2002 | Pharmasset |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pharmasset | For profit | 2 | 2 | 2 | 2002 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1